Oncare

Indicated for animals with a recent oncological diagnosis, high systemic inflammation or autoimmune diseases in the acute phase, its formulation was designed to integrate veterinary clinical protocols without compromising the effect of other ongoing treatments.

✓ Systemic anti-inflammatory modulation in the acute phase
✓ Support for the control of oxidative stress
✓ Formulated to integrate veterinary clinical protocols

Suitable for animals in the chronic phase of stable oncological disease or in oncological remission, it supports the body over time with an ingredient profile designed for continuous immune regulation and metabolic stability in the stabilized chronic phase.

✓ Sustained immune regulation in cats with FeLV and FIV
✓ Modulation of low-grade inflammation in the chronic phase
✓ Long-term metabolic stability